Darwin Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Darwin Wealth Management's LLY Position: Q2 2026 in Review
Darwin Wealth Management increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $7.15K and bringing the position to 342 shares worth $411K. The position accounts for 0.11% of the portfolio, ranked #106.
Darwin Wealth Management first reported a position in LLY in Q1 2020 and has held it in 21 quarters since. The position peaked at $3.27M in Q2 2020. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Darwin Wealth Management held 342 shares of Eli Lilly worth $411K as of Q2 2026.
- Darwin Wealth Management bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
- Eli Lilly made up 0.11% of Darwin Wealth Management's portfolio in Q2 2026, its #106 holding.
- Darwin Wealth Management first reported a position in Eli Lilly in Q1 2020 and has held it in 21 quarters since.
- Darwin Wealth Management's Eli Lilly position peaked at $3.27M in Q2 2020.
- 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.